Symmetric dimethylarginine (SDMA) is a biomarker utilized in veterinary medication to evaluate kidney operate in felines. It’s a modified amino acid launched into circulation throughout protein turnover and is primarily excreted by the kidneys. Elevated ranges of this biomarker in a blood pattern can point out diminished renal operate. For instance, a veterinarian may order this blood take a look at for a cat suspected of getting continual kidney illness (CKD).
The evaluation of this biomarker provides a number of benefits over conventional renal operate checks like creatinine and blood urea nitrogen (BUN). It usually detects kidney dysfunction earlier within the illness course of, permitting for earlier intervention and administration. Earlier detection offers a chance to gradual the development of kidney illness and enhance the animal’s high quality of life. Traditionally, diagnosing kidney points in cats has been difficult because of the often-subtle early medical indicators and limitations of different diagnostic strategies.
